SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED

Shandong Weigao Group Medical Polymer Company Limited

Equities

1066

CNE100000171

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 04:08:23 2024-06-12 EDT			5-day change	1st Jan Change
4.33 ^HKD	-2.04%		-5.25%	-43.10%

05-29	Shandong Weigao Group Medical Polymer Sets Dividend Payment Date	MT
05-28	Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended 31 December 2023	CI

Shandong Weigao Group Medical Polymer Company Limited Announces Re-Designation of Wang Yi as Executive Director

March 14, 2019 at 05:59 am

Shandong Weigao Group Medical Polymer Company Limited announced with effect from 14 March 2019, Mr. Wang Yi has been re-designated from a non- executive director to an executive director of the company.

Latest news about Shandong Weigao Group Medical Polymer Company Limited

Shandong Weigao Group Medical Polymer Sets Dividend Payment Date	05-29	MT
Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended 31 December 2023	05-28	CI
Shandong Weigao Group Medical Polymer Company Limited Approves Board Appointments	05-28	CI
Weigao Group Logs 28% Decline in 2023 Profit	03-26	MT
Shandong Weigao Group Medical Polymer Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024	03-26	CI
Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
Weigao Orthopaedic Device's Chairman Resigns	03-11	MT
Nomura Adjusts Shandong Weigao Group Medical Polymer’s Price Target to HK$8.45 From HK$9.91, Keeps at Buy	03-08	MT
Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023	01-30	CI
Shandong Weigao Group Medical Polymer Company Limited Announces the Resignation of Ni Has Tendered as Executive Director, Effective from 31 December 2023	12-29	CI
Crown International Chairman Resigns; Successor Named	11-10	MT
Shandong Weigao Group Medical Polymer Company Limited Approves Interim Dividend for the Six Months Ended 30 June 2023, Payable on 24 November 2023	23-10-13	CI
Shandong Weigao to Allot Over 97 Million Shares to Staffers	23-09-05	MT
Weigao Group Medical Polymer Slashes Dividend as H1 Profit Declines 16%	23-08-29	MT
Shandong Weigao Group Medical Polymer Company Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 24 November 2023	23-08-29	CI
Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Shandong Weigao Flags Up to 19% Fall in H1 Profit	23-08-09	MT
Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023	23-08-09	CI
Nomura Adjusts Shandong Weigao's Price Target to HK$13.26 From HK14.79, Keeps at Buy	23-08-01	MT
Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended 31 December 2022, Payable on or Before 14 July 2023	23-05-29	CI
Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$14.79 From HK$15.90, Keeps at Buy	23-03-31	MT
Weigao Group Logs 14% Rise in 2022 Profit	23-03-30	MT
Shandong Weigao Group Medical Polymer Company Limited Proposes Ordinary Final Dividend for the Year Ended December 31, 2022, Payable on 14 July 2023	23-03-30	CI
Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Shandong Weigao Orthopaedic Device's 2022 Profit Down 20.8%	23-03-01	MT

Chart Shandong Weigao Group Medical Polymer Company Limited

Duration

Period

Chart Shandong Weigao Group Medical Polymer Company Limited

More charts

Company Profile

Shandong Weigao Group Medical Polymer Co., Ltd. is principally engaged in the research and development, production and sale of single-use medical devices. The Company sells products under brand names of Jierui and Wego Ortho. The Company operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The Company is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Shandong Weigao Group Medical Polymer Company Limited

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.014 CNY

Average target price

7.036 CNY

Spread / Average Target

+75.28%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Supplies

	1st Jan change	Capi.
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-43.10%	2.59B
COLOPLAST A/S	+9.69%	27.32B
HARTALEGA HOLDINGS	+27.41%	2.45B
WINNER MEDICAL CO., LTD.	-22.44%	2.35B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+7.19%	2.26B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-11.31%	1.87B
TOP GLOVE CORPORATION BHD.	+21.11%	1.85B
GVS S.P.A.	+30.76%	1.35B
KOSSAN RUBBER INDUSTRIES	+32.43%	1.33B
NAKANISHI INC.	-1.77%	1.28B

Medical Supplies